S&P 500   3,678.43 (+2.59%)
DOW   29,490.89 (+2.66%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
S&P 500   3,678.43 (+2.59%)
DOW   29,490.89 (+2.66%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
S&P 500   3,678.43 (+2.59%)
DOW   29,490.89 (+2.66%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
S&P 500   3,678.43 (+2.59%)
DOW   29,490.89 (+2.66%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
TSE:JWEL

Jamieson Wellness - JWEL Stock Forecast, Price & News

C$35.00
+1.49 (+4.45%)
(As of 10/3/2022 12:00 AM ET)
Add
Compare
Today's Range
C$33.40
C$35.29
50-Day Range
C$32.61
C$38.10
52-Week Range
C$32.02
C$41.74
Volume
98,766 shs
Average Volume
65,022 shs
Market Capitalization
C$1.45 billion
P/E Ratio
27.13
Dividend Yield
2.03%
Price Target
C$44.16

Jamieson Wellness MarketRank™ Forecast

Analyst Rating
Buy
3.17 Rating Score
Upside/​Downside
26.2% Upside
C$44.16 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
C$1.02 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

JWEL stock logo

About Jamieson Wellness (TSE:JWEL) Stock

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

Receive JWEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jamieson Wellness and its competitors with MarketBeat's FREE daily newsletter.

JWEL Stock News Headlines

3 TSX Small Caps to Buy Right Now
Jamieson Wellness Inc stock raised on Friday.
Jamieson Wellness Inc stock advanced on Thursday.
Jamieson Wellness Inc stock eased on Tuesday.
See More Headlines
Receive JWEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jamieson Wellness and its competitors with MarketBeat's FREE daily newsletter.

JWEL Company Calendar

Ex-Dividend for 9/15 Dividend
8/30/2022
Dividend Payable
9/15/2022
Today
10/03/2022
Next Earnings (Estimated)
11/03/2022

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$44.16
High Stock Price Forecast
C$50.00
Low Stock Price Forecast
C$39.00
Forecasted Upside/Downside
+26.2%
Consensus Rating
Buy
Rating Score (0-4)
3.17
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$457.87 million
Cash Flow
C$0.36 per share
Book Value
C$8.85 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.45 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Michael Pilato (Age 47)
    Pres, CEO & Director
    Comp: $1.36M
  • Mr. Christopher Snowden
    CFO & Corp. Sec.
  • Ms. Regan Stewart
    Chief Operations & People Officer
  • Mr. John Doherty (Age 49)
    Chief Science & Innovation Officer
    Comp: $753.62k
  • Mr. Don Bird (Age 58)
    Exec. VP of USA & Global Strategic Partners
    Comp: $777.44k
  • Ruth Winker
    Corp. Communications Director
  • Mr. Eric Bentz
    Sr. VP of Global Marketing & MD of China
  • Mr. Paul Galbraith
    Sr. VP & MD of Canada
  • Mr. Joel Scales
    Exec. VP of Jamieson Worldwide, Global Strategy & E-Commerce













JWEL Stock - Frequently Asked Questions

Should I buy or sell Jamieson Wellness stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Jamieson Wellness in the last twelve months. There are currently 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" JWEL shares.
View JWEL analyst ratings
or view top-rated stocks.

What is Jamieson Wellness' stock price forecast for 2022?

6 analysts have issued 1 year price targets for Jamieson Wellness' stock. Their JWEL share price forecasts range from C$39.00 to C$50.00. On average, they expect the company's share price to reach C$44.16 in the next year. This suggests a possible upside of 30.0% from the stock's current price.
View analysts price targets for JWEL
or view top-rated stocks among Wall Street analysts.

How have JWEL shares performed in 2022?

Jamieson Wellness' stock was trading at C$40.14 at the beginning of 2022. Since then, JWEL shares have decreased by 15.4% and is now trading at C$33.96.
View the best growth stocks for 2022 here
.

When is Jamieson Wellness' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our JWEL earnings forecast
.

How often does Jamieson Wellness pay dividends? What is the dividend yield for Jamieson Wellness?

Jamieson Wellness announced a quarterly dividend on Tuesday, August 30th. Shareholders of record on Thursday, September 15th will be given a dividend of 0.17 per share on Thursday, September 15th. This represents a $0.68 annualized dividend and a dividend yield of 2.00%. The ex-dividend date of this dividend is Tuesday, August 30th. This is a positive change from the stock's previous quarterly dividend of C$0.15.
Read our dividend analysis for JWEL
.

Is Jamieson Wellness a good dividend stock?

Jamieson Wellness (TSE:JWEL) pays an annual dividend of C$0.60 per share and currently has a dividend yield of 2.03%. The dividend payout ratio is 46.51%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for JWEL.

What other stocks do shareholders of Jamieson Wellness own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jamieson Wellness investors own include Crown Castle (CCI), Enbridge (ENB), Suncor Energy (SU), Canadian Natural Resources (CNQ), Royal Bank of Canada (RY), AltaGas (ALA), BlackBerry (BB), Bank of Montreal (BMO), Algonquin Power & Utilities (AQN) and Bank of Nova Scotia (BNS).

What is Jamieson Wellness' stock symbol?

Jamieson Wellness trades on the Toronto Stock Exchange (TSX) under the ticker symbol "JWEL."

How do I buy shares of Jamieson Wellness?

Shares of JWEL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Jamieson Wellness' stock price today?

One share of JWEL stock can currently be purchased for approximately C$33.96.

How much money does Jamieson Wellness make?

Jamieson Wellness (TSE:JWEL) has a market capitalization of C$1.41 billion and generates C$457.87 million in revenue each year.

How many employees does Jamieson Wellness have?

The company employs 110 workers across the globe.

How can I contact Jamieson Wellness?

Jamieson Wellness' mailing address is 2 St. Clair Avenue West, TORONTO, ON M4V 1L5, Canada. The official website for the company is investors.jamiesonwellness.com. The company can be reached via phone at +1-416-9600052.

This page (TSE:JWEL) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.